DK0758883T3 - Fusogene liposomer og fremgangsmåder til fremstilling af og anvendelse af disse - Google Patents

Fusogene liposomer og fremgangsmåder til fremstilling af og anvendelse af disse

Info

Publication number
DK0758883T3
DK0758883T3 DK94919976T DK94919976T DK0758883T3 DK 0758883 T3 DK0758883 T3 DK 0758883T3 DK 94919976 T DK94919976 T DK 94919976T DK 94919976 T DK94919976 T DK 94919976T DK 0758883 T3 DK0758883 T3 DK 0758883T3
Authority
DK
Denmark
Prior art keywords
lipid
outermost
lipid bilayer
liposome
bilayer
Prior art date
Application number
DK94919976T
Other languages
English (en)
Inventor
Pieter R Cullis
Austin Bailey
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DK0758883T3 publication Critical patent/DK0758883T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94919976T 1994-04-12 1994-04-12 Fusogene liposomer og fremgangsmåder til fremstilling af og anvendelse af disse DK0758883T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003996 WO1995027478A1 (en) 1994-04-12 1994-04-12 Fusogenic liposomes and methods of making and using same

Publications (1)

Publication Number Publication Date
DK0758883T3 true DK0758883T3 (da) 2003-06-02

Family

ID=22242444

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919976T DK0758883T3 (da) 1994-04-12 1994-04-12 Fusogene liposomer og fremgangsmåder til fremstilling af og anvendelse af disse

Country Status (13)

Country Link
EP (1) EP0758883B1 (da)
JP (1) JP3804025B2 (da)
KR (1) KR100315132B1 (da)
AT (1) ATE234605T1 (da)
AU (1) AU689479B2 (da)
CA (1) CA2187748C (da)
DE (1) DE69432320T2 (da)
DK (1) DK0758883T3 (da)
ES (1) ES2196028T3 (da)
FI (1) FI964083A0 (da)
NO (1) NO318814B1 (da)
NZ (1) NZ268146A (da)
WO (1) WO1995027478A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ336539A (en) * 1996-10-15 2000-09-29 Liposome Co Inc Peptide-lipid conjugates, liposomes and liposomal drug delivery
US6339069B1 (en) 1996-10-15 2002-01-15 Elan Pharmaceuticalstechnologies, Inc. Peptide-lipid conjugates, liposomes and lipsomal drug delivery
US6835395B1 (en) 1997-05-14 2004-12-28 The University Of British Columbia Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
DE69841002D1 (de) * 1997-05-14 2009-09-03 Univ British Columbia Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
CA2382611A1 (en) * 1999-08-27 2001-03-08 Inex Pharmaceuticals Corp. Compositions for stimulating cytokine secretion and inducing an immune response
CA2520864A1 (en) 2003-03-31 2004-10-21 Alza Corporation Lipid particles having asymmetric lipid coating and method of preparing same
CN101111306B (zh) 2005-01-28 2010-09-29 独立行政法人科学技术振兴机构 经脱水缩合反应可发生相转移的分子集合体及其相转移方法
EP3494964B1 (en) * 2007-05-14 2021-04-07 Konica Minolta Holdings, Inc. Liposome and method for producing liposome
US9937128B2 (en) * 2009-08-03 2018-04-10 The University Of North Carolina At Chapel Hill Liposomes comprising a calcium phosphate-containing precipitate
TR201901311T4 (tr) 2009-12-01 2019-02-21 Translate Bio Inc İnsan genetik hastalıklarında mRNA'nın teslimi için steroid türevi.
BR112013031553A2 (pt) 2011-06-08 2020-11-10 Shire Human Genetic Therapies, Inc. composições, mrna que codifica para uma hgla e seu uso, uso de pelo menos uma molécula de mrna e um veículo de transferência e uso de um mrna que codifica para proteína exógena
WO2013185067A1 (en) 2012-06-08 2013-12-12 Shire Human Genetic Therapies, Inc. Nuclease resistant polynucleotides and uses thereof
CN105142676B (zh) 2013-03-14 2022-06-28 夏尔人类遗传性治疗公司 Cftr mrna组合物以及相关方法和用途
SG11201507425RA (en) 2013-03-14 2015-10-29 Shire Human Genetic Therapies Methods for purification of messenger rna
EP3060258A1 (en) 2013-10-22 2016-08-31 Shire Human Genetic Therapies, Inc. Mrna therapy for phenylketonuria
EP3501605B1 (en) 2013-10-22 2023-06-28 Translate Bio, Inc. Mrna therapy for argininosuccinate synthetase deficiency
JP6571679B2 (ja) 2014-04-25 2019-09-04 トランスレイト バイオ， インコーポレイテッド メッセンジャーｒｎａの精製方法
AU2018224326B2 (en) 2017-02-27 2024-01-04 Translate Bio, Inc. Novel codon-optimized CFTR mRNA
MA49138A (fr) 2017-05-16 2020-03-25 Translate Bio Inc Traitement de la fibrose kystique par administration d'arnm à codons optimisés codant pour la cftr
CN112930396B (zh) 2018-08-24 2024-05-24 川斯勒佰尔公司 用于纯化信使rna的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946787A (en) * 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
WO1987007530A1 (en) * 1986-06-16 1987-12-17 The Liposome Company, Inc. Induction of asymmetry in vesicles
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
DE4013632A1 (de) * 1990-04-27 1991-10-31 Max Planck Gesellschaft Liposomen mit positiver ueberschussladung
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells

Also Published As

Publication number Publication date
FI964083A (fi) 1996-10-11
NO964284D0 (no) 1996-10-09
EP0758883A1 (en) 1997-02-26
AU689479B2 (en) 1998-04-02
DE69432320T2 (de) 2003-12-04
CA2187748C (en) 2007-04-10
ES2196028T3 (es) 2003-12-16
FI964083A0 (fi) 1996-10-11
ATE234605T1 (de) 2003-04-15
DE69432320D1 (de) 2003-04-24
NZ268146A (en) 1997-10-24
EP0758883B1 (en) 2003-03-19
NO964284L (no) 1996-10-09
JPH09511521A (ja) 1997-11-18
KR100315132B1 (ko) 2002-06-26
NO318814B1 (no) 2005-05-09
WO1995027478A1 (en) 1995-10-19
AU7091594A (en) 1995-10-30
CA2187748A1 (en) 1995-10-19
JP3804025B2 (ja) 2006-08-02

Similar Documents

Publication Publication Date Title
DK0758883T3 (da) Fusogene liposomer og fremgangsmåder til fremstilling af og anvendelse af disse
DK0607118T3 (da) System til administrering af phospholipid
ATE286718T1 (de) Temperatursensitive liposomale formulierung
CA2246456A1 (en) Lipids and their use, for example, in liposomes
AU4711296A (en) Method for loading lipid vesicles
ES2118677T3 (es) Una composicion que comprende un agente activo disuelto en un vehiculo formador de vidrio y un procedimiento para su preparacion.
ES2119354T3 (es) Microcapsulas que contienen suspensiones de compuestos biologicamente activos.
ES2053678T3 (es) Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
CA2293797A1 (en) Aqueous carrier systems for water-insoluble materials
CA2201749A1 (en) Stable aqueous alfa interferon solution formulations
AR020830A1 (es) Formulacion liquida almacenable con formoterol
DK0831779T3 (da) Fremgangsmåde til fremstilling af liposompræparat
TR199902484T2 (xx) Biyolojik y�nden aktif maddeler ihtiva eden yap���c� mikrokaps�ller
ATE184206T1 (de) Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
CA2168260A1 (en) Biphasic Multilamellar Lipid Vesicles
AU2947795A (en) Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability
MX9603515A (es) Preparacion farmaceutica que contiene activadores de plasminogeno.
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
AU2520595A (en) Virosome-mediated intracellular delivery of therapeutic agents
DK0799035T3 (da) Emulsion egnet til indgivelse af et sphingolipid og anvendelse deraf
AU2001258662A1 (en) Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
Szoka Jr et al. Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes
WO1999021533A3 (en) Delivery vehicles for bioactive agents and uses thereof
BE904536A (fr) Liposomes fusogenes et leur procede de fabrication.
GB9827034D0 (en) Delivery formulation